Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Why no alarm bells back home over SEC Gold Fields probe?

Listing shares internationally often carries unwelcome regulatory and compliance risks. This was recently highlighted by the SFO’s corruption probe into the London-listed Kazakh miner ENRC, shortly to be delisted, as well as probes into Indonesia miner and London-listed Bumi plc, and most recently by the SEC’s investigation of South Africa’s Gold Fields, which has a secondary New York listing.… Continue Reading

Keeping it clean in the Philippines

From the Asia Sentinel (September 17, 2013):

“Details started to leak two months ago concerning the vast wealth that businesswoman Janet Lim Napoles had amassed including reportedly 28 houses and a US$2 million condominium in Los Angeles as well as cars, watches and an array of luxury items.… Continue Reading

Meet the Regulators, China Edition

Local criminal and administrative anti-bribery enforcement in China has been much in the news lately. I have received many questions from clients over the years regarding who these different regulators are and what power they have to investigate, prosecute, and enforce criminal and administrative bribery charges.… Continue Reading

‘They followed the leader into FCPA oblivion’

The only U.S.-headquartered company now on the FCPA top ten list is KBR (and its former parent, Halliburton). It landed second after paying $579 million in 2009 to settle an enforcement action for its role in the so-called TSKJ Nigeria consortium.… Continue Reading

Job: Director, Global Integrity & Compliance

Job Title: Director, Global Integrity & Compliance

Employer: Novartis Pharmaceuticals

Location: Fort Worth, Texas

Job Description
 
Supporting the U.S. Business Unit leaders (Surgical) in addressing strategic compliance priorities and coordinating policy establishment, training, communication, monitoring and enforcement activities  .… Continue Reading

China’s changing view of bribe givers

It has been typical under PRC law for bribe takers to be punished more severely than bribe givers. The policy was to punish extortion and incentivize cooperation with government investigations. But as recent investigations into the sales practices of big pharmaceutical companies have shown, this policy may be changing.Continue Reading